[Breast Cancer].
Patients' quality of life(QOL)and/or patient-reported outcomes(PRO)has recently been paid much attention as one of the major health outcomes of breast cancer treatments in Japan. In this report, through a systematic literature review for the evidence of QOL/PRO assessments in clinical study undergoing drug treatments of breast cancer in these several years, I introduced the results of the limited qualified papers from 2017. Moreover, I introduced the results of the large multi-center Japanese survey for alopecia induced by chemotherapy in the recent published paper.